Sun Pharma Q2 FY26 Profit Beats Estimates as India Sales Surge 11%, U.S. Innovative Drugs Outperform

Sun Pharmaceutical Industries, India’s top drugmaker by revenue, reported a quarterly profit above analysts estimates on Wednesday, helped by strong demand for its drugs in the domestic market.The Mumbai-based firm’s consolidated net profit stood at 31.18 billion rupees ($354.7 m

Read More

  • Related Posts

    NCLT Set to Rule on SpiceJet’s Rs 500-Crore Insolvency Battle Today After Lessor Fury

    The National Company Law Tribunal (NCLT) is set to pronounce its verdict on Wednesday in an insolvency petition filed against SpiceJet, in a case that has already drawn a rare rebuke from the bench over the airline’s handling of settlement talks with its creditors.A special bench Read More

    India’s Food Safety Crackdown Intensifies: Restaurants, Quick-Commerce Warehouses, Food Makers Face Action Over Hygiene Violations, Adulteration, Misleading Labels and Expired Stock

    India’s food regulatory bodies have tightened enforcement across India’s food and beverage sector, from labelling standards for spirits makers to hygiene compliance for restaurants and delivery platforms. Several hotels and eateries have been subjected to temporary closure across Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *